---
title: "Rithm Acquisition Corp. got noncompliance notice from NYSE for having less than 300 public stockholders. 45-day grace period."
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/274361612.md"
description: "In New York, the Rithm Acquisition Corp. has reported that it was notified on January 26, 2026, by the New York Stock Exchange about non-compliance with Section 802.01B of the NYSE Listed Company Manual. This section mandates a consistent minimum of 300 public stockholders, which the company failed to maintain. As per NYSE protocols, the company has 45 days from receiving the notice to address this issue."
datetime: "2026-01-30T21:46:54.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/274361612.md)
  - [en](https://longbridge.com/en/news/274361612.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/274361612.md)
---

# Rithm Acquisition Corp. got noncompliance notice from NYSE for having less than 300 public stockholders. 45-day grace period.

In New York, the Rithm Acquisition Corp. has reported that it was notified on January 26, 2026, by the New York Stock Exchange about non-compliance with Section 802.01B of the NYSE Listed Company Manual. This section mandates a consistent minimum of 300 public stockholders, which the company failed to maintain. As per NYSE protocols, the company has 45 days from receiving the notice to address this issue.

### Related Stocks

- [RAC+.US](https://longbridge.com/en/quote/RAC+.US.md)
- [RAC.U.US](https://longbridge.com/en/quote/RAC.U.US.md)
- [RAC.US](https://longbridge.com/en/quote/RAC.US.md)

## Related News & Research

- [ENHANCED NAMES RUMBLE PREMIER PARTNER AND OFFICIAL DISTRIBUTION CHANNEL OF THE ENHANCED GAMES IN CONTENT AGREEMENT | RUM Stock News](https://longbridge.com/en/news/286560804.md)
- [Belite Bio Q1 Net Loss Expands; Plans To Complete Rolling NDA Submission For Tinlarebant In Q2 2026](https://longbridge.com/en/news/287055320.md)
- [Assessing Inventiva (ENXTPA:IVA) Valuation After Recent Share Price Volatility](https://longbridge.com/en/news/286962960.md)
- [GSR V Acquisition Closes $230 Million SPAC IPO; Signs Underwriting, Trust and Rights Agreements](https://longbridge.com/en/news/286821888.md)
- [Goldman Sachs Sticks to Their Buy Rating for Autolus Therapeutics (AUTL)](https://longbridge.com/en/news/286522682.md)